A Study of KHK4827 in Subjects With Palmoplantar Pustulosis

NCT04061252 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

126

Enrollment

INDUSTRY

Sponsor class

Conditions

Palmoplantar Pustulosis

Interventions

DRUG: KHK4827
DRUG: Placebo

Sponsor

Kyowa Kirin Co., Ltd.